BFC Planning’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
BFC Planning's XBI Position: Q3 2026 in Review
BFC Planning increased its State Street SPDR S&P Biotech ETF (XBI) stake by 18% in Q3 2026, buying an estimated $168K and bringing the position to 7,098 shares worth $1.12M. The position accounts for 0.04% of the portfolio, ranked #362.
BFC Planning first reported a position in XBI in Q3 2024 and has held it in 9 quarters since. 820 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- BFC Planning held 7,098 shares of State Street SPDR S&P Biotech ETF worth $1.12M as of Q3 2026.
- BFC Planning bought 1,067 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $168K.
- State Street SPDR S&P Biotech ETF made up 0.04% of BFC Planning's portfolio in Q3 2026, its #362 holding.
- BFC Planning first reported a position in State Street SPDR S&P Biotech ETF in Q3 2024 and has held it in 9 quarters since.
- 820 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.